You do not currently have access to this content.

Cancer Res (2024) 84 (17_Supplement_2): A030.

Prostate cancer (PC) is one of the second most common cancer diagnosed and the second most common cause of cancer death in men worldwide. Currently combinations of tumor surveillance, surgery, ...

ARV-471 is a selective, orally bioavailable PROteolysis-TArgeting Chimera (PROTAC®) small molecule that induces wild-type and mutant estrogen receptor (ER) alpha degradation via the ...

1Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

The Reproducibility Project: Cancer Biology has clearly highlighted the need for published articles to contain more detail of exactly how each study was conducted. This page describes AACR journal ...

Cancer Res (2019) 79 (13_Supplement): 3278.

For authors of Research Articles that have been declined for publication at an AACR journal, the AACR offers the corresponding author the option to easily transfer manuscript files and supporting ...

Crossmark is a multi-publisher initiative from Crossref to provide a standard way for readers to locate the current version of a piece of content. By applying the Crossmark logo, the American ...

Abstract. On November 14, 2022, the FDA granted accelerated approval to mirvetuximab soravtansine-gynx for treatment of adult patients with folate receptor-α (FRα)-positive, platinum-resistant ...

Cancer Res (2024) 84 (7_Supplement): CT160.